Thomas Lindhorst is co-founder and managing director of UGISense AG. Thomas is one of the developers of the Ugimers™, the UGISense antisense technology. Before joining UGISense AG, he was co-founder of ugichem GmbH, Germany and Austria where he served as Chief Scientific Officer. Thomas is a serial entrepreneur with more than 20 years experience. He holds a Ph.D. in chemistry from the Technical University of Munich and is co-author of several publications and patents.

Birgit Werner is a co-founder and managing director of UGISense AG. Birgit is one of the developers of the Ugimers™, the UGISense antisense technology. Prior to joining UGISense AG, she co-founded ugichem GmbH, Austria and was ugichem’s Head of Chemistry. In that role Birgit was instrumental in developing modified and customized Peptide Nucleic Acid (PNA) drugs. Birgit has more than 20 years entrepreneurial experience in the life sciences. She holds a PhD in chemistry from the Technical University of Munich and is co-author of several publications and patents.

Nicole Faust is an independent consultant in the biotechnology sector. She is the former CEO of CEVEC Pharmaceuticals, now part of Cytiva, with more than 20 years of management experience in biotech. She held leadership positions with Lonza and Taconic Biosciences. She has a scientific background in stem cell biology and gene regulation and holds a PhD in cell and molecular biology from University of Freiburg and an MBA from Educatis University, Switzerland. She is well connected in the cell and gene therapy community and the former chair of the ARM gene therapy advisory committee.